However, the proper balance between NF‐κB, Nrf2, and NADPH oxidase activity, or their relationship with OS, and anti‐and pro‐inflammatory interleukins has not been previously investigated in IBS. This evidence concerns the gene NFKB1 and irritable bowel syndrome.